A 61-y-old woman was attended by our team. She had suffered a chest traumatism resulting in three right costal fractures with multiple costoesternal desinsertion. It determined a functional ‘volet’ ...
CorMedix CRMD has experienced significant growth in 2025, fueled by the strong uptake of the company’s lead marketed drug, ...
Patients are being discharged on home nutrition by TPN by way of PICC lines and Ports. The most common serious complication is line sepsis or blood clots. (Patients) should not be exposed to ...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening ...
High-dose chemotherapy followed by autologous SCT is increasingly being used in the treatment of patients with hematological diseases and has in the past two decades also been used in the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback